Laminar Pharmaceuticals, a biopharmaceutical company based at ParcBit in Palma and in Massachusetts, is preparing a clinical study to treat Covid-19. Pablo Escribá, professor of biology at the University of the Balearic Islands and founder of Laminar, says that the study could begin in a few months. It will be into molecules that inhibit fusion of the virus membrane.
Coronavirus
Palma company preparing clinical trials of Covid-19 inhibitor
Also in News
- Spain wants Britons to show they have 113.40 euros, £97, per day for their holidays
- Major security alert at Mallorca airport, surprise landing of flights from Morocco and Namibia
- Big changes on the horizon when Britons travel to Mallorca
- Over two hours for Britons to get through Palma airport queues
- Living in a motorhome in Palma: "It'll only get worse"
No comments
To be able to write a comment, you have to be registered and logged in
Currently there are no comments.